摘要:目的评价FEP与FEM两种化疗方案双途径介入治疗原发性肝癌的疗效及安全性.方法95例肝癌,男81例,女14例.年龄32~72岁(中位年龄46岁).其中FEP组48例、FEM组47例.全部病例均采用动脉灌注及化疗栓塞技术,FEP组选用化疗药物5-氟脲嘧啶,表阿霉素、顺铂,FEM组选用5-氟脲嘧啶、表阿霉素、丝裂霉素,并联合经皮穿刺无水酒精注射.结果FEP组总有效率54.2%(26/48),中位生存期21.2个月.FEM组总有效率34%(16/47),中位生存期14.6个月.FEP组及FEM组病人1、2、3年生存率分别为89.6%、43.8%、29.2%及85.1%、29.8%、14.9%.FEP组及FEM组病人总有效率、中位生存期及3年生存率经统计学检验具有显著性差异(P<0.05).结论双途径介入治疗对提高肝癌疗效有重要的临床价值,FEP方案较FEM方案为优.
注:因版权方要求,不能公开全文,如需全文,请咨询杂志社
热门期刊服务
Transactions of Nonferrous Metals Society of China Journal of Bionic Engineering Journal of Earth Science Journal of Rare Earths Chinese Journal of Chemical Engineering Frontiers of Information Technology Electronic Engineering Chinese Journal of Mechanical Engineering Journal of Genetics and Genomics Journal of Systems Engineering and Electronics Journal of Iron and Steel Research Chinese Annals of Mathematics Series B Journal of Integrative Plant Biology